Skip to content
Open access

Curcuma longa potentiates the anticonvulsant and neuroprotective effects of diazepam in a pentylenetetrazol-induced seizure model

Oct 2026 · ANPAbstract_CBN26 · 0 citations

Abstract

Background: Epilepsy is one of the most prevalent neurological disorders worldwide. Despite the availability of effective medications, approximately one-third of patients do not respond adequately to treatment. Therefore, new treatments are needed to mitigate epileptic seizures. For this reason, curcumin, a bioactive compound extracted from Curcuma longa, was investigated for its anticonvulsant properties and potentiating effects when used in combination with diazepam. Objective: To evaluate the anticonvulsant and neuroprotective effects of Curcuma longa, alone and in combination with diazepam, in a pentylenetetrazol-induced seizure model, using behavioral, electrophysiological, and histological analyses. Methods: Seventy-two male Wistar rats were used, divided into eight groups, treated with saline, Curcuma longa administered as purified curcumin (80 mg/kg), diazepam (5 mg/kg), or a combination of both, with or without seizure induction. The animals were pretreated for four days via gavage, and on the fifth day, they received pentylenetetrazol to induce seizures. Following induction, electroencephalogram and electromyography recordings were performed for 15 minutes, in addition to behavioral assessment of the seizures. After seven days, the animals were euthanized, and the brains were subjected to Nissl staining for histological analysis and neuronal counting in the CA1 and CA3 regions of the hippocampus. The data were analyzed using normality tests, Student’s t-test, and ANOVA, with a significance level of p < 0.05. Results: Pretreatment with Curcuma longa and diazepam significantly increased the latency to the onset of pentylenetetrazol-induced seizures, rising from approximately 47 s in the control group to over 300 s in the treated groups, with the combination being the most effective, yielding latencies exceeding 600–800 s for clonic events. In electroencephalogram recordings, pentylenetetrazol increased amplitude and total power, while the treatments reduced these parameters, with greater efficacy in the combination therapy (≈0.08 mV and 1.34 ± 0.36 mV²/Hz ×10⁻³). Similarly, electromyography recordings demonstrated reduced muscle activity, with amplitudes reaching ~0.5 mV in the pentylenetetrazol group, which were significantly attenuated by the treatments. Furthermore, histological analysis revealed significant neuronal loss in the CA1 and CA3 regions following pentylenetetrazol, while the treatments, especially the combination, promoted greater cellular preservation. Conclusion: The combination of Curcuma longa and diazepam produced superior anticonvulsant and neuroprotective effects compared to the treatments alone, indicating a possible synergistic effect in modulating epileptiform activity and preserving hippocampal neurons. These findings suggest that Curcuma longa may act as a therapeutic adjunct in the treatment of epilepsy. However, further studies are needed to elucidate the molecular mechanisms involved and evaluate its clinical applicability.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.